FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma

Affiliations

Ophthalmology Innovation Center, Santen Inc., Emeryville, CA, United States; Singapore Eye Research Institute, Singapore; Eye-ACP Duke-National University of Singapore Medical School, Singapore; Department of Pharmacology and Neuroscience, University of North Texas Health Sciences Center, Fort Worth, TX, United States; Department of Pharmacy Sciences, Creighton University, Omaha, NE, United States; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, United States; Imperial College of Science and Technology, St. Mary's Campus, London, United Kingdom; Institute of Ophthalmology, University College London, London, United Kingdom; Product Development Division, Santen Pharmaceutical Co., Ltd., Osaka, Japan; Product Development Division, Santen Inc., Emeryville, CA, United States; Biomedical Engineering Department, University of Miami, Miami, FL, United States